E Allen, IB Walters… - Clinical Cancer Research, 2011 - AACR Experimental Design: An anti-VEGFR2 monoclonal antibody (DC101), an inhibitor of FGF signaling (FGF ligand trap), sorafenib, and brivanib were comparatively evaluated in first-line monotherapy in short and longer term fixed endpoint intervention trials in the RIP-Tag2 mouse model of ... Cited by 2
B Acar-Perk, J Weimer, K Koch, A Salmassi… - Human …, 2011 - ESHRE Results: 10648 AID cycles were performed from January,2007 to September, 2009 in our Hospital and resulted in 2364 clinical pregnancies,the clinical preg- nancy rate was 22.20%. All 10648 cycles were followed up completely and the follow-up rate was 100%.The average age of ...
G Francia, W Cruz-Munoz, S Man, P Xu… - Nature Reviews …, 2011 - nature.com An enduring problem in cancer research is the failure to reproduce highly encouraging preclinical therapeutic findings using transplanted or spontaneous primary tumours in mice in clinical trials of patients with advanced metastatic disease. There are several reasons for this, ... Cited by 9 - Related articles - All 4 versions
[PDF] from nyu.eduP Pandiyan, HR Conti, L Zheng, AC Peterson… - Immunity, 2011 - Elsevier Th17 cells and CD4 + CD25 + Foxp3 + regulatory T (Treg) cells are thought to promote and suppress inflammatory responses, respectively. Here we explore why under Th17 cell polarizing conditions, Treg cells did not suppress, but rather upregulated, the expression of ... Cited by 7 - Related articles - All 3 versions
[HTML] from nih.govR Jain, KA Engleka, SL Rentschler… - The Journal of …, 2011 - ncbi.nlm.nih.gov Congenital anomalies of the aortic valve are common and are associated with progressive valvular insufficiency and/or stenosis. In addition, aneurysm, coarctation, and dissection of the ascending aorta and aortic arch are often associated conditions that complicate patient management ... Cited by 2 - Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
